HYNIC-iPSMA (TFA)
Product Specifications
UNSPSC Description
Target Antigen
PSMA; Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related;Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hynic-ipsma-tfa.html
Purity
99.28
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(C(F)(F)F)=O.O=C(C(C=C/1)=CNC1=N\N)N[C@H](C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)CC2=CC3=C(C=CC=C3)C=C2
Molecular Weight
765.69
References & Citations
[1]Ferro-Flores G, et al. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Nucl Med Biol. 2017 May;48:36-44.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5292A/HYNIC-iPSMA-TFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5292A/HYNIC-iPSMA-TFA-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2375849-11-7
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items